Reports for GE HEALTHCARE CANADA INC
Company Name
GE HEALTHCARE CANADA INC
Totals |
||
Shortage reports |
69 |
|
| Actual shortage: | 1 (1%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 5 (7%) | |
| Resolved: | 63 (91%) | |
Discontinuation Reports |
5 |
|
| To be discontinued: | 1 (20%) | |
| Discontinued: | 4 (80%) | |
| Reversed: | 0 (0%) | |
Late reports |
0 (0%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| OMNIPAQUE 240 | 518MG | SOLUTION | Avoided shortage | 2022-05-13 | 2022-05-20 | 160522 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2022-05-13 | 2023-03-01 | 160525 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Actual shortage | 2022-05-13 | 2023-03-15 | 160528 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-11 | 160531 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2022-06-03 | 2022-09-09 | 161863 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2022-10-03 | 2022-11-01 | 170954 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Avoided shortage | 2022-11-30 | 2023-01-25 | 176387 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2021-08-18 | 2021-08-25 | 144299 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-04-01 | 2022-04-19 | 157813 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-05-12 | 2023-03-01 | 160389 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-07 | 160534 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-17 | 160537 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-05 | 160540 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-17 | 160562 |
| OMNIPAQUE 350 | 755MG | SOLUTION | Resolved | 2021-08-06 | 2021-08-13 | 143789 |
| OMNIPAQUE 350 | 755MG | SOLUTION | Resolved | 2022-04-11 | 2022-04-22 | 158491 |
| OMNIPAQUE 350 | 755MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-17 | 160543 |
| OMNIPAQUE 350 | 755MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-05 | 160546 |
| OMNIPAQUE 350 | 755MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-05 | 160549 |
| OMNIPAQUE 350 | 755MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-05 | 160552 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| Metastron | 37 MBq/mL | Solution | Discontinued | 2018-10-12 | 2019-02-01 | 63929 |
| OMNIPAQUE 180 | 388MG | SOLUTION | Discontinued | 2023-01-31 | 2023-02-22 | 182757 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Discontinued | 2023-01-31 | 2023-03-18 | 182760 |
| OMNISCAN | 287MG | SOLUTION | To be discontinued | 2023-01-31 | 2023-01-31 | 182742 |
| THALLOUS CHLORIDE TI 201 INJECTION | 37MBq | SOLUTION | Discontinued | 2020-12-04 | 2021-06-05 | 129592 |
Showing 1 to 5 of 5